BDRX
Biodexa Pharmaceticals
NASDAQ: BDRX · HEALTHCARE · BIOTECHNOLOGY
$3.14
-3.09% today
Updated 2026-04-30
Market cap
$2.14M
P/E ratio
—
P/S ratio
0.58x
EPS (TTM)
$-3.38
Dividend yield
—
52W range
$3 – $97
Volume
2.5M
Biodexa Pharmaceticals (BDRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.22M | $5.17M | $46.66M | $64.04M | $56.69M | $49.22M | $20.44M | $30.89M | $9.82M | $12.91M | $5.53M | $10.54M | $14.78M |
| Cash & equivalents | $133000.00 | $2.39M | $30.32M | $16.18M | $17.61M | $13.20M | $2.34M | $10.93M | $7.55M | $10.06M | $2.84M | $5.97M | $1.67M |
| Current assets | $1.10M | $4.09M | $31.63M | $20.33M | $22.30M | $18.58M | $5.62M | $13.74M | $9.28M | $11.76M | $4.69M | $7.03M | $8.81M |
| Total liabilities | $7.31M | $4.41M | $4.67M | $17.15M | $10.96M | $14.55M | $3.52M | $11.34M | $3.10M | $2.46M | $2.36M | $5.86M | $6.46M |
| Current liabilities | $5.07M | $2.29M | $2.83M | $9.10M | $9.35M | $8.36M | $2.47M | $5.67M | $2.99M | $1.84M | $1.90M | $5.57M | $5.03M |
| Long-term debt | — | — | — | — | — | — | — | $4.76M | $0.00 | $0.00 | — | — | — |
| Shareholder equity | $-5.09M | $760000.00 | $41.99M | $46.89M | $45.72M | $34.68M | $16.92M | $19.56M | $6.72M | $10.45M | $3.16M | $4.68M | $8.32M |
| Retained earnings | $-17.19M | $-20.40M | $-29.22M | $-39.15M | $-59.11M | $-74.65M | $-89.72M | $-99.84M | $-122.43M | $-127.80M | $-135.34M | $-144.77M | $-150.42M |
| Accounts receivable | — | $160000.00 | $189000.00 | $985000.00 | $1.43M | $2.23M | $89000.00 | $1.81M | $95000.00 | $33000.00 | $329000.00 | $704000.00 | $715000.00 |
| Inventory | — | — | — | $459000.00 | $817000.00 | $941000.00 | — | $1.00 | $-1.38M | $1.00 | $1.00 | $-704000.00 | — |
| Goodwill | — | — | $2.29M | $12.46M | $14.49M | $13.44M | $2.29M | $2.29M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |